Long-term response with the atypical reaction to nivolumab in microsatellite stability metastatic colorectal cancer: A case report
{{output}}
Immunotherapy has become an integral part of a comprehensive treatment approach to metastatic colorectal cancer (mCRC). Nivolumab (Opdivo) is a human immunoglobulin G4 monoclonal antibody that blocks the interaction between the programmed cell death 1 (PD-1) r... ...
